{
  "id": 5110443,
  "title": "Teva says gluten challenge study succeeds in celiac disease",
  "url": "https://urgent.news/2026/09/02/teva-says-gluten-challenge-study-succeeds-in-celiac-disease",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-02T14:58:42.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/teva-says-gluten-challenge-study-succeeds-in-celiac-disease/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A single injection of an experimental antibody significantly reduced intestinal damage among people with celiac disease who then ate gluten daily, Teva Pharmaceuticals said Wednesday. The Israeli drugmaking giant reported topline ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute",
        "url": "https://urgent.news/2026/09/02/teva-claims-success-in-celiac-study-biomarin-ascendis-settle-patent",
        "published": "2026-09-02T14:12:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}